SlideShare ist ein Scribd-Unternehmen logo
1 von 39
DILEMMAS IN DIAGNOSIS
AND MANAGEMENT OF FGR
Dr. Niranjan Chavan
National FOGSI Conference – Obstetric Dilemmas
06th August 2022
Professor and Unit Chief, L.T.M.M.C & L.T.M.G.H, Sion Hospital
Joint Treasurer, FOGSI (2021-2024)
President, MOGS (2022-2023)
Member Oncology Committee, SAFOG (2021-2023)
Joint Secretary, AFG(2022-2023)
Dean AGOG & Chief Content Director, HIGHGRAD & FEMAS Courses
Editor-in-Chief, FEMAS, JGOG & TOA Journal
60 publications in International and National Journals with 109 Citations
National Coordinator, FOGSI Medical Disorders in Pregnancy Committee (2019-2022)
Chair & Convener, FOGSI Cell Violence Against Doctors (2015-16)
Member, Oncology Committee AOFOG (2013-2015)
Coordinator of 11 batches of MUHS recognized Certificate Course of B.I.M.I.E at L.T.M.G.H (2010-16)
Member, Managing Committee IAGE (2013-17), (2018-20), (2022-2023)
Editorial Board, European Journal of Gynaec. Oncology (Italy)
Course Coordinator of 3 batches of Advanced Minimal Access Gynaec Surgery (AMAS) at LTMGH
(2018-19)
DR. NIRANJAN CHAVAN
MD, FCPS, DGO, MICOG, DICOG, FICOG, DFP,
DIPLOMA IN ENDOSCOPY (USA)
“
”
EVERY CHILD COMES WITH THE MESSAGE THAT GOD
IS NOT YET DISCOURAGED OF MAN
Rabindranath Tagore
FETAL GROWTH RESTRICTION
• Fetal growth restriction (FGR) is a pathological condition in
which a fetus fails to achieve its genetic growth potential
• It comes under a much broader concept of small for
gestational age (SGA) fetuses
• SGA also carries under it babies that are constitutionally small
but have achieved their growth potential and hence are not
associated with adverse perinatal outcomes, much unlike FGR
fetuses
• FGR can be classified grossly as ones beginning before 32 of
gestation (early FGR) vs the ones after (late FGR)
• 3 - 5% of all pregnancies
• 20 % of still borns are growth restricted
• 1/3 of infants with BW < 2750 gms are growth
restricted and not premature
• Only 20-30% of growth restricted fetuses are small
due to pathological restriction of growth
• Perinatal mortality is 8 - 10 times higher for these
fetuses
INCIDENCE
AETIOLOGY
• General-
• Racial / Ethnic origin, Small maternal / paternal height
/weight, Fetal sex
• Maternal causes
• Fetal causes
• Placental causes
• Idiopathic - In a majority of cases (40%) the cause is
unknown– probably due to placental insufficiency
• Previous baby who suffered from
IUGR
• Extremes of age
• Is small in size (Ht & Wt)
• Has poor weight gain and
malnutrition during pregnancy
• Is socially deprived
• Has a low total blood volume
during early pregnancy
MATERNAL RISK FACTORS
• Uses substances (like tobacco,
narcotics, alcohol) that can cause
abnormal development or birth
defects
• Multiple Gestation
• High altitude
• Has a cardio-vascular disease-
preeclampsia, hypertension,
cyanotic heart disease, cardiac
disease Grade III & IV, diabetic
vascular lesions
• Chronic kidney disease
• Chronic infection- UTI, Malaria, TB, genital
infections
• Has an antibody problem that can make
successful pregnancy difficult (antiphospholipid
antibody syndrome, SLE)
MATERNAL RISK FACTORS
• Intrauterine infections - German measles (rubella), cytomegalovirus, herpes
simplex, tuberculosis, syphilis, or toxoplasmosis, TB, Malaria, Parvo virus
B19
• A birth defect (cardiovascular, renal, anencephaly, limb defect, etc)
• A chromosome defect - Trisomy-18 (Edwards’ syndrome), 21(Down’s
syndrome), 16, 13, XO (Turner’s syndrome)
• Primary disorder of bone or cartilage
• Chronic lack of oxygen during development (hypoxia)
• Placenta or umbilical cord defects
• Exposure to Teratogens/Drugs(Anti-convulsant, Anticoagulants, Alcohol,
Narcotics)
FETAL RISK FACTORS
• Uteroplacental insufficiency resulting from -
• Improper / inadequate trophoblastic invasion
and placentation in the first trimester
• Lateral insertion of placenta
• Reduced maternal blood flow to the placental
bed
• Fetoplacetal insufficiency due to -
• Vascular anomalies of placenta and cord
• Decreased placental functioning mass
• Small placenta, abruptio placenta, placenta
previa, post term pregnancy
PLACENTAL FACTORS
NORMAL INTRAUTERINE GROWTH PATTERN
• Stage I (Hyperplasia)
• 4 to 20 weeks
• Rapid mitosis
• Increase of DNA content
• Stage II (Hyperplasia & Hypertrophy)
• 20 to 28 weeks
• Declining mitosis
• Increase in cell size
• Stage III ( Hypertrophy)
• 28 to 40 weeks
• Rapid increase in cell size
• Rapid accumulation of fat, muscle and
connective tissue
95% of fetal weight gain occurs during last 20 weeks of gestations
• The optimal definition of growth restriction, in particular the differentiation between physiological (SGA) and
pathological (IUGR) small fetal size, is one of the most common, controversial, and complex problems in modern
obstetrics
• There is greement internationally that an EFW <10th centile for gestation should alert clinicians to potential small
fetal size
• All fetuses with an EFW <3rd centile, or those fetuses with a combination of EFW <10th centile and abnormal
UA Doppler, are at increased risk of either adverse perinatal outcome or NICU admission when compared to
those with EFW or AC <10th or <5th centiles or normal UA Doppler indices
DEFINING FGR USING USG
For less than 32 weeks:
1. AC/EFW < 3rd centile or,
2. AEDF in the Umbilical Artery (UA) or,
3. AC/EFW < 10th centile + Uterine Artery (UtA) and/or UA PI > 95th centile
For more than 32 weeks:
1. AC/EFW < 3rd centile or,
2. AC/EFW < 10th centile + UA PI > 95th centile or CPR < 5th centile
INDIVIDUAL DOPPLER INDICES AND FGR
Placental Development Indicators:
• Uterine Artery Doppler: Carries a moderate
degree of predictive value for adverse perinatal
outcome when performed between 20-24
weeks of gestation. Persistence of these
changes carries higher risk.
• Umbilical Artery Doppler: With increasing
gestation, a gradual decrease in PI is normally
seen. Whereas in patients with poor
trophoblastic invasion, this is reversed
Fetal Indices:
• Middle Cerebral Artery Doppler: Normally the PI increases with
course of gestation, but as a result of chronic hypoxemia, there is
cerebral vasodilation and decreased PI and CPR, leading to brain
sparing effect.
• Develops before 32 weeks when there was already impaired
placentation or after 32 weeks when fetal metabolic demands
exceed normal placental limits
• Ductus Venosus Doppler: Increased PI and retrograde a wave
reflects onset of overt cardiac compromise
AFI AND FGR
• Amniotic fluid index is an indicator of fetal renal
perfusion, which lower values reflecting
shunting of blood from kidneys to the brain
• Deepest vertical pocket is a better indicator
than AFI as a predictor of fetal well being over
last 2-3 weeks
Early-Onset FGR Minimum Surveillance
Frequency
UA Doppler PI >95th centile, no other
testing abnormalities
Every 2 weeks Doppler, weekly
BPS or cCTG
Low MCA PI or CPR Weekly Doppler with BPS or cCTG
UA absent end-diastolic flow
(AEDF)
Consider admission, twice weekly
Doppler with BPS or cCTG
UA reversed end-diastolic flow,
increased DV or oligoamnios
(deepest pool <2 cm)
Admission, 3 times per week Doppler
with BPS, daily CTG or cCTG
Absent or reversed DV
a-wave
Daily Doppler with BPS or cCTG
in preparation to delivery
Late-Onset FGR Minimum Surveillance
Frequency
UA Doppler PI >95th centile, no other
testing abnormalities
Weekly Doppler with BPS
Low MCA PI or CPR 2-3 times/week Doppler with BPS
Minimum Surveillance Frequency Prior to the
Delivery Threshold
TEMPORAL SEQUENCE OF FETAL DOPPLER
ABNORMALITIES IN GROWTH RESTRICTED
FETUS
SEQUENTIAL CHANGES IN TESTS OF FETAL
WELL BEING IN UTEROPLACENTAL FAILURE
ROLE OF DOPPLER IN SELECTIVE FGR
• sFGR, conventionally, is defined as a condition in which
one fetus has EFW < 10th centile and the intertwin EFW
discordance is > 25%
• According to the NICE guidance (year), EFW
discordance should be calculated and documented at
every scan from 20 weeks onwards.
• If this discordance reaches 25% or more, increased fetal
surveillance, including fetal Doppler, and planning of
delivery when appropriate , is warranted
CLASSIFICATION OF MONOCHORIONIC TWIN
PREGNANCY COMPLICATED BY SFGR
Classification of sFGR in monochorionic twins
depends on the pattern of end-diastolic velocity
at umbilical artery Doppler -
In Type I, the umbilical artery Doppler waveform
has positive end-diastolic flow. The survival rate
in Type-I sFGR is greater than 90% (in-utero
mortality rates of up to 4%).
• In Type II, there is absent or reversed
end-diastolic flow (AREDF).
• Type-II, sFGR is associated with
• A high risk of IUD of the growth-
restricted twin a and/or
• Very preterm delivery with associated risk
of neurodevelopmental delay if the other
twin survives (IUD of either twin in up to
29% and
• Risk of neurological sequelae in up to
15% of cases born prior to 30 weeks)
• In Type III, there is a cyclical/intermittent
pattern of AREDF.
• Type-III sFGR is associated with a 10–20%
risk of sudden death of the growth-
restricted fetus, which is unpredictable
(even in cases in which ultrasound features
have been stable).
• There is also a high (up to 20%) associated
rate of neurological morbidity in the
surviving larger twin
MONITORING CASES WITH SFGR
• In monochorionic twin pregnancy complicated by sFGR, fetal growth
should be assessed at least every 2 weeks, and fetal Doppler (umbilical
artery and MCA) at least weekly
• If the umbilical artery Doppler is abnormal, an assessment of the DV blood
flow should be undertaken
• The aim in managing these pregnancies is to prolong the pregnancy at
least until viability is achieved, while at the same time avoiding a single IUD
with its associated severe consequences for the surviving cotwin
• 8.8% neonates delivered had birth weight of<2.5 kg out of which 20% had intrauterine growth restriction and
22.4% were preterm
• 40% babies delivered had birth weight of <2.5 kg out of which 13.33% had IUGR and 26.66% were preterm
CASE 1
• 32 year G2P1L1 k/c/o GDM on
PI 8-8-8 came at 38 weeks by
scan
• On examination BP was
160/100 mm Hg
• P/A –
• Ut 34 weeks, Cephal, FHS
regular 150-160 bpm, relaxed
• Doppler Findings –
• Raised PI of Umbilical Artery
• Absent End Diastolic flow (AEDF)
at fetal site
• Raised PI of Left uterine artery
with Early Diastolic notch
• Pathological CPR with Reduced
PI of MCA s/o brain sparing
effect
• What is the next step in Management?
• Features are suggestive of Late onset IUGR
• Immediate delivery by caesarean section after steroid cover if CTG facility available
CASE 2
• 26 year old primigravida 32
weeks B/S came with BP-
160/110 with premonitory
symptoms
• P/A- Ut 24-26 weeks,
Cephal, fhs regular 140-150
bpm, relaxed
USG Findings –
• Single live intrauterine gestation of
approximate gestational age of 29-
30 weeks
• Scanty liquor – AFI 1-2
• Relatively smaller abdominal
parameter
• EFW – 1137+/- 166gms
• Above findings suggest IUGR
• Fetoplacental insufficiency with
absent diastolic flow on Colour
Doppler
• No evidence of utero-placental
insufficiency on Colour Doppler
What is the next step in management?
• Immediate delivery after stabilization and control of Blood
Pressure
CASE 3
• 24 year primigravida with 32.3
weeks BS came with raised BP of
140/90 mm Hg for the first time,
UA trace, knee jerks normal, no
PMS
• P/A- Ut 30 week size, cephal, FHS
regular at 130-140 bpm, relaxed
• USG Obs doppler done
Doppler Findings –
• Raised PI of Umbilical Artery
• B/L Uterine artery shows Early
Diastolic Notch
What will be your plan of action?
• Late Onset IUGR with only Raised PI of Umbilical Artery
• Weekly Doppler with Biophysical Score
TAKE HOME MESSAGES
• Fetal growth restriction (FGR) is a pathological condition in which a fetus
fails to achieve its genetic growth potential
• FGR can be Early or Late Onset depending upon gestational age at occurrence
• Abnormal Umbilical Artery Doppler and EFW < 3rd centile were strongly and most
consistently associated with adverse perinatal outcome
• All fetuses with an EFW < 3rd centile, or those fetuses with a combination of EFW
< 10th centile and abnormal UA Doppler, are at increased risk of either adverse
perinatal outcome or NICU admission when compared to those with EFW or AC <
10th or < 5th centiles or normal UA Doppler indices
REFERENCES
1. Badawi N, Kurinczuk JJ, Keogh JM, et al. Antepartum risk factors for newborn encephalopathy: the
Western Australian case-control study. BMJ 1998;317:1549-53.
2. Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006; 49:270-83.
3. American College of Obstetricians and Gynecologists. Intrauterine growth restriction. Wash- ington, DC:
American College of Obstetricians and Gynecologists; 2000.
4. Royal College of Obstetricians and Gynecologists. The investigation and management of the small-for-
gestational-age fetus (guideline no. 31). London: Royal College of Obstetricians and Gynecologists;
2002.
5. Lausman A, McCarthy FP, Walker M, Kingdom J. Screening, diagnosis, and management of intrauterine
growth restriction. J Obstet Gynaecol Can 2012;34:17-28.
6. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customized antenatal growth charts. Lancet
1992;339:283-7
7. Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of intrauterine growth restriction: the
multicenter prospective PORTO Study. Am J Obstet Gynecol 2013;208:290.e1-6.
QUOTE
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx

Weitere ähnliche Inhalte

Was ist angesagt?

Tubal factor and fertility by Dr.Gayathiri
Tubal factor and fertility by Dr.GayathiriTubal factor and fertility by Dr.Gayathiri
Tubal factor and fertility by Dr.Gayathiri
Morris Jawahar
 
Vaginal birth after cesarean section
Vaginal  birth after cesarean sectionVaginal  birth after cesarean section
Vaginal birth after cesarean section
hemnathsubedii
 
DNB Obstetrics & gynaecology previous Year Question Papers
DNB Obstetrics & gynaecology previous Year Question PapersDNB Obstetrics & gynaecology previous Year Question Papers
DNB Obstetrics & gynaecology previous Year Question Papers
apollobgslibrary
 

Was ist angesagt? (20)

Role of Stem Cells in Obstetrics and Gynecology Practice
Role of Stem Cells in Obstetrics and Gynecology PracticeRole of Stem Cells in Obstetrics and Gynecology Practice
Role of Stem Cells in Obstetrics and Gynecology Practice
 
Internal iliac ligation
Internal iliac ligationInternal iliac ligation
Internal iliac ligation
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Tubal factor and fertility by Dr.Gayathiri
Tubal factor and fertility by Dr.GayathiriTubal factor and fertility by Dr.Gayathiri
Tubal factor and fertility by Dr.Gayathiri
 
Recurrent pregnancy loss
Recurrent pregnancy loss Recurrent pregnancy loss
Recurrent pregnancy loss
 
Stem cells in gynecology
Stem cells in gynecologyStem cells in gynecology
Stem cells in gynecology
 
Endometriosis and Infertility
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
 
Vaginal birth after cesarean section
Vaginal  birth after cesarean sectionVaginal  birth after cesarean section
Vaginal birth after cesarean section
 
Ovarian classification and Management
Ovarian classification and ManagementOvarian classification and Management
Ovarian classification and Management
 
DNB Obstetrics & gynaecology previous Year Question Papers
DNB Obstetrics & gynaecology previous Year Question PapersDNB Obstetrics & gynaecology previous Year Question Papers
DNB Obstetrics & gynaecology previous Year Question Papers
 
Shirodkar sling surgery
Shirodkar sling surgeryShirodkar sling surgery
Shirodkar sling surgery
 
Ovarian Stimulation Protocols
Ovarian Stimulation ProtocolsOvarian Stimulation Protocols
Ovarian Stimulation Protocols
 
Uterus Transplantation Utx (obstetric and gynecology)
Uterus Transplantation Utx (obstetric and gynecology) Uterus Transplantation Utx (obstetric and gynecology)
Uterus Transplantation Utx (obstetric and gynecology)
 
Reproductive organ transplantation
Reproductive organ transplantationReproductive organ transplantation
Reproductive organ transplantation
 
Fetal growth restriction
Fetal growth restrictionFetal growth restriction
Fetal growth restriction
 
Cervical and broad ligament fibroid
Cervical and broad ligament fibroidCervical and broad ligament fibroid
Cervical and broad ligament fibroid
 
Adenomyosis and Assisted Conception
Adenomyosis and Assisted Conception Adenomyosis and Assisted Conception
Adenomyosis and Assisted Conception
 
Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts
Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts
Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts
 
Fetal growth restriction:Evidence based management 2018
Fetal growth restriction:Evidence based management 2018Fetal growth restriction:Evidence based management 2018
Fetal growth restriction:Evidence based management 2018
 
Purandares cervicopexy
Purandares cervicopexyPurandares cervicopexy
Purandares cervicopexy
 

Ähnlich wie Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx

Hypertensive disorders in pregnancy dr. betha fe m. castillo 102413
Hypertensive disorders in pregnancy   dr. betha fe m. castillo 102413Hypertensive disorders in pregnancy   dr. betha fe m. castillo 102413
Hypertensive disorders in pregnancy dr. betha fe m. castillo 102413
Jesart De Vera
 
Antepartum fetal surveillance
Antepartum fetal surveillanceAntepartum fetal surveillance
Antepartum fetal surveillance
Jason Zachariah
 

Ähnlich wie Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx (20)

Iugr by dr derar ismerat
Iugr by dr derar ismeratIugr by dr derar ismerat
Iugr by dr derar ismerat
 
IUGR.pptx
IUGR.pptxIUGR.pptx
IUGR.pptx
 
0. Classification of Newborn.pptx
0. Classification of Newborn.pptx0. Classification of Newborn.pptx
0. Classification of Newborn.pptx
 
Intrauterine growth restriction Intrauterine growth restriction
Intrauterine growth restriction Intrauterine growth restrictionIntrauterine growth restriction Intrauterine growth restriction
Intrauterine growth restriction Intrauterine growth restriction
 
IUGR
IUGRIUGR
IUGR
 
Hypertensive disorders in pregnancy dr. betha fe m. castillo 102413
Hypertensive disorders in pregnancy   dr. betha fe m. castillo 102413Hypertensive disorders in pregnancy   dr. betha fe m. castillo 102413
Hypertensive disorders in pregnancy dr. betha fe m. castillo 102413
 
Intrauterine growth restriction
Intrauterine growth restrictionIntrauterine growth restriction
Intrauterine growth restriction
 
IUGR
IUGRIUGR
IUGR
 
IUGR PPT.pptx
IUGR PPT.pptxIUGR PPT.pptx
IUGR PPT.pptx
 
Fetal surveillance
Fetal surveillanceFetal surveillance
Fetal surveillance
 
Iugr
IugrIugr
Iugr
 
Intrauterinegrowthrestriction 130120060505-phpapp02 - copy
Intrauterinegrowthrestriction 130120060505-phpapp02 - copyIntrauterinegrowthrestriction 130120060505-phpapp02 - copy
Intrauterinegrowthrestriction 130120060505-phpapp02 - copy
 
Iugr obs
Iugr obsIugr obs
Iugr obs
 
IUGR.pptx
IUGR.pptxIUGR.pptx
IUGR.pptx
 
Fetal Growth Restriction.pptx
Fetal Growth Restriction.pptxFetal Growth Restriction.pptx
Fetal Growth Restriction.pptx
 
3.Intrauterine Fetal Death (IUFD).pptx
3.Intrauterine Fetal Death (IUFD).pptx3.Intrauterine Fetal Death (IUFD).pptx
3.Intrauterine Fetal Death (IUFD).pptx
 
Antepartum fetal surveillance
Antepartum fetal surveillanceAntepartum fetal surveillance
Antepartum fetal surveillance
 
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCE
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCEF.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCE
F.G.R. PANEL DISCUSSION AT FOGSI BOH CONFERENCE
 
Triplet pregnancy
Triplet pregnancyTriplet pregnancy
Triplet pregnancy
 
SCREENING OF HIGH RISK PREGNANCY NEWER MODALITIES OF_110313.pptx
SCREENING OF HIGH RISK PREGNANCY NEWER MODALITIES OF_110313.pptxSCREENING OF HIGH RISK PREGNANCY NEWER MODALITIES OF_110313.pptx
SCREENING OF HIGH RISK PREGNANCY NEWER MODALITIES OF_110313.pptx
 

Mehr von Niranjan Chavan

Mehr von Niranjan Chavan (20)

Case Report on Invasive Mole. Gestational Trophoblastic Neoplasia (GTN) encom...
Case Report on Invasive Mole. Gestational Trophoblastic Neoplasia (GTN) encom...Case Report on Invasive Mole. Gestational Trophoblastic Neoplasia (GTN) encom...
Case Report on Invasive Mole. Gestational Trophoblastic Neoplasia (GTN) encom...
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
DR. NNC LAPAROSCOPY IN PREGNANCY IAGE VARANASI, 17TH MARCH 2024.pptx
DR. NNC LAPAROSCOPY IN PREGNANCY IAGE VARANASI, 17TH MARCH 2024.pptxDR. NNC LAPAROSCOPY IN PREGNANCY IAGE VARANASI, 17TH MARCH 2024.pptx
DR. NNC LAPAROSCOPY IN PREGNANCY IAGE VARANASI, 17TH MARCH 2024.pptx
 
Dr. NN Chavan Keynote address on ADNEXAL MASS- APPROACH TO MANAGEMENT in the...
Dr. NN Chavan Keynote address on ADNEXAL MASS-  APPROACH TO MANAGEMENT in the...Dr. NN Chavan Keynote address on ADNEXAL MASS-  APPROACH TO MANAGEMENT in the...
Dr. NN Chavan Keynote address on ADNEXAL MASS- APPROACH TO MANAGEMENT in the...
 
Optimising Delivery Of 1kg Fetus - Special Considerations.pptx
Optimising Delivery Of 1kg Fetus - Special Considerations.pptxOptimising Delivery Of 1kg Fetus - Special Considerations.pptx
Optimising Delivery Of 1kg Fetus - Special Considerations.pptx
 
Seminar on FIBROIDS by Dr. N.N. Chavan Unit.pptx
Seminar on FIBROIDS by Dr. N.N. Chavan Unit.pptxSeminar on FIBROIDS by Dr. N.N. Chavan Unit.pptx
Seminar on FIBROIDS by Dr. N.N. Chavan Unit.pptx
 
VACCINE IN WOMEN TOWARDS SDG 2030 DR.N N CHAVAN 10012024 AICOG HYDERABAD.pptx
VACCINE IN WOMEN TOWARDS SDG 2030 DR.N N CHAVAN 10012024 AICOG HYDERABAD.pptxVACCINE IN WOMEN TOWARDS SDG 2030 DR.N N CHAVAN 10012024 AICOG HYDERABAD.pptx
VACCINE IN WOMEN TOWARDS SDG 2030 DR.N N CHAVAN 10012024 AICOG HYDERABAD.pptx
 
RRRR IN OBSTETRIC HEMORRHAGE 09012024 AICOG 2024 HEYDERABAD.pptx
RRRR IN OBSTETRIC HEMORRHAGE 09012024 AICOG 2024 HEYDERABAD.pptxRRRR IN OBSTETRIC HEMORRHAGE 09012024 AICOG 2024 HEYDERABAD.pptx
RRRR IN OBSTETRIC HEMORRHAGE 09012024 AICOG 2024 HEYDERABAD.pptx
 
Anemia is a condition in which the number of red blood cells and/OR their oxy...
Anemia is a condition in which the number of red blood cells and/OR their oxy...Anemia is a condition in which the number of red blood cells and/OR their oxy...
Anemia is a condition in which the number of red blood cells and/OR their oxy...
 
HELLP syndrome is a pregnancy complication. It is a type of preeclampsia. It ...
HELLP syndrome is a pregnancy complication. It is a type of preeclampsia. It ...HELLP syndrome is a pregnancy complication. It is a type of preeclampsia. It ...
HELLP syndrome is a pregnancy complication. It is a type of preeclampsia. It ...
 
Guidelines & Identification of Early Sepsis DR. NN CHAVAN 02122023.pptx
Guidelines & Identification of Early Sepsis DR. NN CHAVAN 02122023.pptxGuidelines & Identification of Early Sepsis DR. NN CHAVAN 02122023.pptx
Guidelines & Identification of Early Sepsis DR. NN CHAVAN 02122023.pptx
 
SURGICAL MANAGEMENT OF CERVICAL CANCER DR. NN CHAVAN 28102023.pptx
SURGICAL MANAGEMENT OF CERVICAL CANCER DR. NN CHAVAN 28102023.pptxSURGICAL MANAGEMENT OF CERVICAL CANCER DR. NN CHAVAN 28102023.pptx
SURGICAL MANAGEMENT OF CERVICAL CANCER DR. NN CHAVAN 28102023.pptx
 
Malignant ovarian tumors DR NN CHAVAN 19102023 .pptx
Malignant ovarian tumors DR NN CHAVAN 19102023 .pptxMalignant ovarian tumors DR NN CHAVAN 19102023 .pptx
Malignant ovarian tumors DR NN CHAVAN 19102023 .pptx
 
PAST, PRESENT AND FUTURE IN OBGYN INFECTIONS 01102023.pptx
PAST, PRESENT AND FUTURE IN OBGYN INFECTIONS 01102023.pptxPAST, PRESENT AND FUTURE IN OBGYN INFECTIONS 01102023.pptx
PAST, PRESENT AND FUTURE IN OBGYN INFECTIONS 01102023.pptx
 
Respiratory Disorders In Pregnancy 26092023.pptx
Respiratory Disorders In Pregnancy 26092023.pptxRespiratory Disorders In Pregnancy 26092023.pptx
Respiratory Disorders In Pregnancy 26092023.pptx
 
VACCINATION IN PREGNANCY 25092023.pptx
VACCINATION IN PREGNANCY 25092023.pptxVACCINATION IN PREGNANCY 25092023.pptx
VACCINATION IN PREGNANCY 25092023.pptx
 
DR.NNC INVASIVE CERVICAL CARCINOMA 20092023.pptx
DR.NNC INVASIVE CERVICAL CARCINOMA 20092023.pptxDR.NNC INVASIVE CERVICAL CARCINOMA 20092023.pptx
DR.NNC INVASIVE CERVICAL CARCINOMA 20092023.pptx
 
Dr NNC Hyperhomocysteinemia & Pregnancy 06082023.pptx
Dr NNC Hyperhomocysteinemia & Pregnancy 06082023.pptxDr NNC Hyperhomocysteinemia & Pregnancy 06082023.pptx
Dr NNC Hyperhomocysteinemia & Pregnancy 06082023.pptx
 
Why Wound Gape ? - Optimising Post Surgical Wound Healing
Why Wound Gape ? - Optimising Post Surgical Wound HealingWhy Wound Gape ? - Optimising Post Surgical Wound Healing
Why Wound Gape ? - Optimising Post Surgical Wound Healing
 
PLACENTA ACCRETA SPECTRUM DISORDERS.pptx
PLACENTA ACCRETA SPECTRUM DISORDERS.pptxPLACENTA ACCRETA SPECTRUM DISORDERS.pptx
PLACENTA ACCRETA SPECTRUM DISORDERS.pptx
 

Kürzlich hochgeladen

Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
mahaiklolahd
 

Kürzlich hochgeladen (20)

Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
 
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
 
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
 
Most Beautiful Call Girl in Bangalore Contact on Whatsapp
Most Beautiful Call Girl in Bangalore Contact on WhatsappMost Beautiful Call Girl in Bangalore Contact on Whatsapp
Most Beautiful Call Girl in Bangalore Contact on Whatsapp
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
 
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
Best Rate (Patna ) Call Girls Patna ⟟ 8617370543 ⟟ High Class Call Girl In 5 ...
 
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service AvailableTrichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
 
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
 
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
 
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
 
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
 
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
 
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
 

Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx

  • 1. DILEMMAS IN DIAGNOSIS AND MANAGEMENT OF FGR Dr. Niranjan Chavan National FOGSI Conference – Obstetric Dilemmas 06th August 2022
  • 2. Professor and Unit Chief, L.T.M.M.C & L.T.M.G.H, Sion Hospital Joint Treasurer, FOGSI (2021-2024) President, MOGS (2022-2023) Member Oncology Committee, SAFOG (2021-2023) Joint Secretary, AFG(2022-2023) Dean AGOG & Chief Content Director, HIGHGRAD & FEMAS Courses Editor-in-Chief, FEMAS, JGOG & TOA Journal 60 publications in International and National Journals with 109 Citations National Coordinator, FOGSI Medical Disorders in Pregnancy Committee (2019-2022) Chair & Convener, FOGSI Cell Violence Against Doctors (2015-16) Member, Oncology Committee AOFOG (2013-2015) Coordinator of 11 batches of MUHS recognized Certificate Course of B.I.M.I.E at L.T.M.G.H (2010-16) Member, Managing Committee IAGE (2013-17), (2018-20), (2022-2023) Editorial Board, European Journal of Gynaec. Oncology (Italy) Course Coordinator of 3 batches of Advanced Minimal Access Gynaec Surgery (AMAS) at LTMGH (2018-19) DR. NIRANJAN CHAVAN MD, FCPS, DGO, MICOG, DICOG, FICOG, DFP, DIPLOMA IN ENDOSCOPY (USA)
  • 3. “ ” EVERY CHILD COMES WITH THE MESSAGE THAT GOD IS NOT YET DISCOURAGED OF MAN Rabindranath Tagore
  • 4. FETAL GROWTH RESTRICTION • Fetal growth restriction (FGR) is a pathological condition in which a fetus fails to achieve its genetic growth potential • It comes under a much broader concept of small for gestational age (SGA) fetuses • SGA also carries under it babies that are constitutionally small but have achieved their growth potential and hence are not associated with adverse perinatal outcomes, much unlike FGR fetuses • FGR can be classified grossly as ones beginning before 32 of gestation (early FGR) vs the ones after (late FGR)
  • 5. • 3 - 5% of all pregnancies • 20 % of still borns are growth restricted • 1/3 of infants with BW < 2750 gms are growth restricted and not premature • Only 20-30% of growth restricted fetuses are small due to pathological restriction of growth • Perinatal mortality is 8 - 10 times higher for these fetuses INCIDENCE
  • 6. AETIOLOGY • General- • Racial / Ethnic origin, Small maternal / paternal height /weight, Fetal sex • Maternal causes • Fetal causes • Placental causes • Idiopathic - In a majority of cases (40%) the cause is unknown– probably due to placental insufficiency
  • 7. • Previous baby who suffered from IUGR • Extremes of age • Is small in size (Ht & Wt) • Has poor weight gain and malnutrition during pregnancy • Is socially deprived • Has a low total blood volume during early pregnancy MATERNAL RISK FACTORS
  • 8. • Uses substances (like tobacco, narcotics, alcohol) that can cause abnormal development or birth defects • Multiple Gestation • High altitude • Has a cardio-vascular disease- preeclampsia, hypertension, cyanotic heart disease, cardiac disease Grade III & IV, diabetic vascular lesions
  • 9. • Chronic kidney disease • Chronic infection- UTI, Malaria, TB, genital infections • Has an antibody problem that can make successful pregnancy difficult (antiphospholipid antibody syndrome, SLE) MATERNAL RISK FACTORS
  • 10. • Intrauterine infections - German measles (rubella), cytomegalovirus, herpes simplex, tuberculosis, syphilis, or toxoplasmosis, TB, Malaria, Parvo virus B19 • A birth defect (cardiovascular, renal, anencephaly, limb defect, etc) • A chromosome defect - Trisomy-18 (Edwards’ syndrome), 21(Down’s syndrome), 16, 13, XO (Turner’s syndrome) • Primary disorder of bone or cartilage • Chronic lack of oxygen during development (hypoxia) • Placenta or umbilical cord defects • Exposure to Teratogens/Drugs(Anti-convulsant, Anticoagulants, Alcohol, Narcotics) FETAL RISK FACTORS
  • 11. • Uteroplacental insufficiency resulting from - • Improper / inadequate trophoblastic invasion and placentation in the first trimester • Lateral insertion of placenta • Reduced maternal blood flow to the placental bed • Fetoplacetal insufficiency due to - • Vascular anomalies of placenta and cord • Decreased placental functioning mass • Small placenta, abruptio placenta, placenta previa, post term pregnancy PLACENTAL FACTORS
  • 12. NORMAL INTRAUTERINE GROWTH PATTERN • Stage I (Hyperplasia) • 4 to 20 weeks • Rapid mitosis • Increase of DNA content • Stage II (Hyperplasia & Hypertrophy) • 20 to 28 weeks • Declining mitosis • Increase in cell size • Stage III ( Hypertrophy) • 28 to 40 weeks • Rapid increase in cell size • Rapid accumulation of fat, muscle and connective tissue 95% of fetal weight gain occurs during last 20 weeks of gestations
  • 13. • The optimal definition of growth restriction, in particular the differentiation between physiological (SGA) and pathological (IUGR) small fetal size, is one of the most common, controversial, and complex problems in modern obstetrics • There is greement internationally that an EFW <10th centile for gestation should alert clinicians to potential small fetal size • All fetuses with an EFW <3rd centile, or those fetuses with a combination of EFW <10th centile and abnormal UA Doppler, are at increased risk of either adverse perinatal outcome or NICU admission when compared to those with EFW or AC <10th or <5th centiles or normal UA Doppler indices
  • 14. DEFINING FGR USING USG For less than 32 weeks: 1. AC/EFW < 3rd centile or, 2. AEDF in the Umbilical Artery (UA) or, 3. AC/EFW < 10th centile + Uterine Artery (UtA) and/or UA PI > 95th centile For more than 32 weeks: 1. AC/EFW < 3rd centile or, 2. AC/EFW < 10th centile + UA PI > 95th centile or CPR < 5th centile
  • 15.
  • 16. INDIVIDUAL DOPPLER INDICES AND FGR Placental Development Indicators: • Uterine Artery Doppler: Carries a moderate degree of predictive value for adverse perinatal outcome when performed between 20-24 weeks of gestation. Persistence of these changes carries higher risk. • Umbilical Artery Doppler: With increasing gestation, a gradual decrease in PI is normally seen. Whereas in patients with poor trophoblastic invasion, this is reversed
  • 17. Fetal Indices: • Middle Cerebral Artery Doppler: Normally the PI increases with course of gestation, but as a result of chronic hypoxemia, there is cerebral vasodilation and decreased PI and CPR, leading to brain sparing effect. • Develops before 32 weeks when there was already impaired placentation or after 32 weeks when fetal metabolic demands exceed normal placental limits • Ductus Venosus Doppler: Increased PI and retrograde a wave reflects onset of overt cardiac compromise
  • 18. AFI AND FGR • Amniotic fluid index is an indicator of fetal renal perfusion, which lower values reflecting shunting of blood from kidneys to the brain • Deepest vertical pocket is a better indicator than AFI as a predictor of fetal well being over last 2-3 weeks
  • 19. Early-Onset FGR Minimum Surveillance Frequency UA Doppler PI >95th centile, no other testing abnormalities Every 2 weeks Doppler, weekly BPS or cCTG Low MCA PI or CPR Weekly Doppler with BPS or cCTG UA absent end-diastolic flow (AEDF) Consider admission, twice weekly Doppler with BPS or cCTG UA reversed end-diastolic flow, increased DV or oligoamnios (deepest pool <2 cm) Admission, 3 times per week Doppler with BPS, daily CTG or cCTG Absent or reversed DV a-wave Daily Doppler with BPS or cCTG in preparation to delivery Late-Onset FGR Minimum Surveillance Frequency UA Doppler PI >95th centile, no other testing abnormalities Weekly Doppler with BPS Low MCA PI or CPR 2-3 times/week Doppler with BPS Minimum Surveillance Frequency Prior to the Delivery Threshold
  • 20. TEMPORAL SEQUENCE OF FETAL DOPPLER ABNORMALITIES IN GROWTH RESTRICTED FETUS
  • 21. SEQUENTIAL CHANGES IN TESTS OF FETAL WELL BEING IN UTEROPLACENTAL FAILURE
  • 22.
  • 23. ROLE OF DOPPLER IN SELECTIVE FGR • sFGR, conventionally, is defined as a condition in which one fetus has EFW < 10th centile and the intertwin EFW discordance is > 25% • According to the NICE guidance (year), EFW discordance should be calculated and documented at every scan from 20 weeks onwards. • If this discordance reaches 25% or more, increased fetal surveillance, including fetal Doppler, and planning of delivery when appropriate , is warranted
  • 24. CLASSIFICATION OF MONOCHORIONIC TWIN PREGNANCY COMPLICATED BY SFGR Classification of sFGR in monochorionic twins depends on the pattern of end-diastolic velocity at umbilical artery Doppler - In Type I, the umbilical artery Doppler waveform has positive end-diastolic flow. The survival rate in Type-I sFGR is greater than 90% (in-utero mortality rates of up to 4%).
  • 25. • In Type II, there is absent or reversed end-diastolic flow (AREDF). • Type-II, sFGR is associated with • A high risk of IUD of the growth- restricted twin a and/or • Very preterm delivery with associated risk of neurodevelopmental delay if the other twin survives (IUD of either twin in up to 29% and • Risk of neurological sequelae in up to 15% of cases born prior to 30 weeks)
  • 26. • In Type III, there is a cyclical/intermittent pattern of AREDF. • Type-III sFGR is associated with a 10–20% risk of sudden death of the growth- restricted fetus, which is unpredictable (even in cases in which ultrasound features have been stable). • There is also a high (up to 20%) associated rate of neurological morbidity in the surviving larger twin
  • 27. MONITORING CASES WITH SFGR • In monochorionic twin pregnancy complicated by sFGR, fetal growth should be assessed at least every 2 weeks, and fetal Doppler (umbilical artery and MCA) at least weekly • If the umbilical artery Doppler is abnormal, an assessment of the DV blood flow should be undertaken • The aim in managing these pregnancies is to prolong the pregnancy at least until viability is achieved, while at the same time avoiding a single IUD with its associated severe consequences for the surviving cotwin
  • 28. • 8.8% neonates delivered had birth weight of<2.5 kg out of which 20% had intrauterine growth restriction and 22.4% were preterm
  • 29. • 40% babies delivered had birth weight of <2.5 kg out of which 13.33% had IUGR and 26.66% were preterm
  • 30. CASE 1 • 32 year G2P1L1 k/c/o GDM on PI 8-8-8 came at 38 weeks by scan • On examination BP was 160/100 mm Hg • P/A – • Ut 34 weeks, Cephal, FHS regular 150-160 bpm, relaxed • Doppler Findings – • Raised PI of Umbilical Artery • Absent End Diastolic flow (AEDF) at fetal site • Raised PI of Left uterine artery with Early Diastolic notch • Pathological CPR with Reduced PI of MCA s/o brain sparing effect • What is the next step in Management?
  • 31. • Features are suggestive of Late onset IUGR • Immediate delivery by caesarean section after steroid cover if CTG facility available
  • 32. CASE 2 • 26 year old primigravida 32 weeks B/S came with BP- 160/110 with premonitory symptoms • P/A- Ut 24-26 weeks, Cephal, fhs regular 140-150 bpm, relaxed USG Findings – • Single live intrauterine gestation of approximate gestational age of 29- 30 weeks • Scanty liquor – AFI 1-2 • Relatively smaller abdominal parameter • EFW – 1137+/- 166gms • Above findings suggest IUGR • Fetoplacental insufficiency with absent diastolic flow on Colour Doppler • No evidence of utero-placental insufficiency on Colour Doppler What is the next step in management?
  • 33. • Immediate delivery after stabilization and control of Blood Pressure
  • 34. CASE 3 • 24 year primigravida with 32.3 weeks BS came with raised BP of 140/90 mm Hg for the first time, UA trace, knee jerks normal, no PMS • P/A- Ut 30 week size, cephal, FHS regular at 130-140 bpm, relaxed • USG Obs doppler done Doppler Findings – • Raised PI of Umbilical Artery • B/L Uterine artery shows Early Diastolic Notch What will be your plan of action?
  • 35. • Late Onset IUGR with only Raised PI of Umbilical Artery • Weekly Doppler with Biophysical Score
  • 36. TAKE HOME MESSAGES • Fetal growth restriction (FGR) is a pathological condition in which a fetus fails to achieve its genetic growth potential • FGR can be Early or Late Onset depending upon gestational age at occurrence • Abnormal Umbilical Artery Doppler and EFW < 3rd centile were strongly and most consistently associated with adverse perinatal outcome • All fetuses with an EFW < 3rd centile, or those fetuses with a combination of EFW < 10th centile and abnormal UA Doppler, are at increased risk of either adverse perinatal outcome or NICU admission when compared to those with EFW or AC < 10th or < 5th centiles or normal UA Doppler indices
  • 37. REFERENCES 1. Badawi N, Kurinczuk JJ, Keogh JM, et al. Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 1998;317:1549-53. 2. Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006; 49:270-83. 3. American College of Obstetricians and Gynecologists. Intrauterine growth restriction. Wash- ington, DC: American College of Obstetricians and Gynecologists; 2000. 4. Royal College of Obstetricians and Gynecologists. The investigation and management of the small-for- gestational-age fetus (guideline no. 31). London: Royal College of Obstetricians and Gynecologists; 2002. 5. Lausman A, McCarthy FP, Walker M, Kingdom J. Screening, diagnosis, and management of intrauterine growth restriction. J Obstet Gynaecol Can 2012;34:17-28. 6. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customized antenatal growth charts. Lancet 1992;339:283-7 7. Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol 2013;208:290.e1-6.
  • 38. QUOTE